Study links COVID-19 to rise in childhood type 1 diabetes

Published 2020-08-18, 09:58 a/m

By Kate Kelland

LONDON (Reuters) - Cases of type 1 diabetes among children in a small UK study almost doubled during the peak of Britain's COVID-19 epidemic, suggesting a possible link between the two diseases that needs more investigation, scientists said on Tuesday.

While the study is based on only a handful of cases, it is the first to link COVID-19 and new-onset type 1 diabetes in children, and doctors should be on the look-out, the Imperial College London researchers said.

"Our analysis shows that during the peak of the pandemic the number of new cases of type 1 diabetes in children was unusually high in two of the hospitals (we studied) compared to previous years," said Karen Logan, who co-led the study.

"When we investigated further, some of these children had active coronavirus or had previously been exposed to the virus."

Logan said previous reports from China and Italy had noted that children were being diagnosed in hospitals with new-onset type 1 diabetes during the pandemic.

This study, published in the Diabetes Care journal, analysed data from 30 children in London hospitals diagnosed with new-onset type 1 diabetes during the first peak of the pandemic -- around double the cases seen in this period in previous years.

Twenty-one of the children were tested for COVID-19 or had antibody tests to see whether they had been exposed to the virus -- and five tested positive for novel coronavirus infection.

Type 1 diabetes causes insulin-producing cells in the pancreas to be destroyed, preventing the body from producing enough insulin to regulate blood sugar levels. The Imperial team said one possible explanation might be that the novel coronavirus' spike protein might attack insulin-making cells in the pancreas.

© Reuters. People wearing face masks walk near Qianmen Street on a rainy day, following the coronavirus disease (COVID-19) outbreak, in Beijing

"More research is needed to establish whether there is a definitive link, ... but in the meantime we hope clinicians will be mindful of this," Logan said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.